| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,517 |
4,534 |
$465K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,407 |
3,118 |
$164K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,777 |
3,873 |
$92K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,835 |
3,194 |
$57K |
| 88342 |
|
1,165 |
793 |
$37K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,836 |
3,194 |
$34K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
3,268 |
2,656 |
$32K |
| 87481 |
|
2,427 |
1,248 |
$29K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
1,856 |
1,739 |
$26K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,456 |
1,344 |
$18K |
| 81513 |
|
211 |
191 |
$17K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,217 |
1,039 |
$17K |
| 88304 |
|
844 |
717 |
$14K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
757 |
485 |
$7K |
| 99001 |
|
5,505 |
4,530 |
$7K |
| 87511 |
|
753 |
486 |
$7K |
| 88312 |
|
122 |
58 |
$5K |
| 88341 |
|
68 |
40 |
$2K |
| 87653 |
|
109 |
100 |
$2K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
159 |
128 |
$919.71 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
12 |
$502.80 |
| G0141 |
Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician |
84 |
82 |
$473.00 |
| 88313 |
|
14 |
12 |
$412.50 |
| 88141 |
|
51 |
44 |
$92.96 |
| 87081 |
|
15 |
12 |
$42.34 |
| 99000 |
|
14 |
13 |
$0.00 |